Adaptive ERK signalling activation in response to therapy and in silico prognostic evaluation of EGFR-MAPK in HNSCC.

With the exception of MAPK1, differential expression of all other genes was highly significant between the high-risk as compared to the low-risk group (Fig. 4c ).

also in 132,142 other papers